Utility of the ALSFRS‐R for predicting ALS and comorbid disease neuropathology: The Veterans Affairs Biorepository Brain Bank. Issue 2 (4th June 2022)
- Record Type:
- Journal Article
- Title:
- Utility of the ALSFRS‐R for predicting ALS and comorbid disease neuropathology: The Veterans Affairs Biorepository Brain Bank. Issue 2 (4th June 2022)
- Main Title:
- Utility of the ALSFRS‐R for predicting ALS and comorbid disease neuropathology: The Veterans Affairs Biorepository Brain Bank
- Authors:
- Colvin, Leigh E.
Foster, Zachariah W.
Stein, Thor D.
Thakore‐James, Manisha
Salajegheh, Mohammad Kian
Carr, Kendall
Spencer, Keith R.
Abdul Rauf, Nazifa
Adams, Latease
Averill, James G.
Walker, Sean E.
Robey, Ian
Alvarez, Victor E.
Huber, Bertrand R.
McKee, Ann C.
Kowall, Neil W.
Brady, Christopher B. - Abstract:
- Abstract: Introduction/Aims: The amyotrophic lateral sclerosis (ALS) functional rating scale‐revised (ALSFRS‐R) is commonly used to track ALS disease progression; however, there are gaps in the literature regarding the extent to which the ALSFRS‐R relates to underlying central nervous system (CNS) pathology. The current study explored the association between ALSFRS‐R (total and subdomain) scores and postmortem neuropathology (both ALS‐specific and comorbid disease). Methods: Within our sample of 93 military veterans with autopsy‐confirmed ALS, we utilized hierarchical cluster analysis (HCA) to identify discrete profiles of motor dysfunction based on ALSFRS‐R subdomain scores. We examined whether emergent clusters were associated with neuropathology. Separate analyses of variance and covariance with post‐hoc comparisons were performed to examine relevant cluster differences. Results: Analyses revealed significant correlations between ALSFRS‐R total and subdomain scores with some, but not all, neuropathological variables. The HCA illustrated three groups: Cluster 1—predominantly diffuse functional impairment; Cluster 2—spared respiratory/bulbar and impaired motor function; and Cluster 3—spared bulbar and impaired respiratory, and fine and gross motor function. Individuals in Cluster 1 (and to a lesser degree, Cluster 3) exhibited greater accumulation of ALS‐specific neuropathology and less comorbid neuropathology than those in Cluster 2. Discussion: These results suggest thatAbstract: Introduction/Aims: The amyotrophic lateral sclerosis (ALS) functional rating scale‐revised (ALSFRS‐R) is commonly used to track ALS disease progression; however, there are gaps in the literature regarding the extent to which the ALSFRS‐R relates to underlying central nervous system (CNS) pathology. The current study explored the association between ALSFRS‐R (total and subdomain) scores and postmortem neuropathology (both ALS‐specific and comorbid disease). Methods: Within our sample of 93 military veterans with autopsy‐confirmed ALS, we utilized hierarchical cluster analysis (HCA) to identify discrete profiles of motor dysfunction based on ALSFRS‐R subdomain scores. We examined whether emergent clusters were associated with neuropathology. Separate analyses of variance and covariance with post‐hoc comparisons were performed to examine relevant cluster differences. Results: Analyses revealed significant correlations between ALSFRS‐R total and subdomain scores with some, but not all, neuropathological variables. The HCA illustrated three groups: Cluster 1—predominantly diffuse functional impairment; Cluster 2—spared respiratory/bulbar and impaired motor function; and Cluster 3—spared bulbar and impaired respiratory, and fine and gross motor function. Individuals in Cluster 1 (and to a lesser degree, Cluster 3) exhibited greater accumulation of ALS‐specific neuropathology and less comorbid neuropathology than those in Cluster 2. Discussion: These results suggest that discrete patterns of motor dysfunction based on ALSFRS‐R subdomain scores are related to postmortem neuropathology. Findings support use of ALSFRS‐R subdomain scores to capture the heterogeneity of clinical presentation and disease progression in ALS, and may assist researchers in identifying endophenotypes for separate assessment in clinical trials. … (more)
- Is Part Of:
- Muscle & nerve. Volume 66:Issue 2(2022)
- Journal:
- Muscle & nerve
- Issue:
- Volume 66:Issue 2(2022)
- Issue Display:
- Volume 66, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 66
- Issue:
- 2
- Issue Sort Value:
- 2022-0066-0002-0000
- Page Start:
- 167
- Page End:
- 174
- Publication Date:
- 2022-06-04
- Subjects:
- amyotrophic lateral sclerosis -- cluster analysis -- functional rating scale -- neuropathology
Neuromuscular diseases -- Periodicals
Muscles -- Periodicals
Nerves -- Periodicals
616.74 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-4598 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/mus.27635 ↗
- Languages:
- English
- ISSNs:
- 0148-639X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5986.493000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22605.xml